Vaccine Therapy in Treating Patients With Advanced Melanoma

Completed · Phase 1

Conditions studied: Intraocular Melanoma, Malignant Conjunctival Neoplasm, Melanoma (Skin)

In brief

RATIONALE: Vaccine therapy may help the body build an effective immune response to kill tumor cells. PURPOSE: This randomized clinical trial is studying how well vaccine therapy works in treating patients with advanced melanoma.

Key facts

Study ID

NCT00705640

Run by

Craig L Slingluff, Jr

People needed

45

Starts

2008-05-01

Last updated by the study team

2016-12-16

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Virginia Cancer Center — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.